Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.
about
Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseasesHistone deacetylase signaling in cardioprotectionReview of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studiesRegulation of CaMKII signaling in cardiovascular diseaseSignaling effectors underlying pathologic growth and remodeling of the heartCaMKII regulation of cardiac K channelsCalmodulin-dependent protein kinase II: linking heart failure and arrhythmiasMechanisms of altered Ca²⁺ handling in heart failureNew therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII)CaMKIIdelta subtypes: localization and functionTargets for therapy in sarcomeric cardiomyopathiesRole of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death.miR-185 plays an anti-hypertrophic role in the heart via multiple targets in the calcium-signaling pathwaysAAV-mediated knock-down of HRC exacerbates transverse aorta constriction-induced heart failureRepression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophyThe δA isoform of calmodulin kinase II mediates pathological cardiac hypertrophy by interfering with the HDAC4-MEF2 signaling pathwayLocation matters: clarifying the concept of nuclear and cytosolic CaMKII subtypesCaMKIIδB mediates aberrant NCX1 expression and the imbalance of NCX1/SERCA in transverse aortic constriction-induced failing heartRole of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failureDiabetes increases mortality after myocardial infarction by oxidizing CaMKIIVoltage-Gated Sodium Channel Phosphorylation at Ser571 Regulates Late Current, Arrhythmia, and Cardiac Function In Vivo.Oxidized calmodulin kinase II regulates conduction following myocardial infarction: a computational analysis.Role of RyR2 phosphorylation in heart failure and arrhythmias: Controversies around ryanodine receptor phosphorylation in cardiac disease.Protein Kinase Signaling at the Crossroads of Myocyte Life and Death in Ischemic Heart Disease.Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic miceCardiac Protection of Valsartan on Juvenile Rats with Heart Failure by Inhibiting Activity of CaMKII via Attenuating Phosphorylation.Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stressesCaV1.2 beta-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizationsElectrical remodeling in the failing heart.β-Adrenergic receptor subtype signaling in heart: from bench to bedside.beta-Arrestin-dependent activation of Ca(2+)/calmodulin kinase II after beta(1)-adrenergic receptor stimulation.Aging and CaMKII alter intracellular Ca2+ transients and heart rhythm in Drosophila melanogaster.Intracellular translocation of calmodulin and Ca2+/calmodulin-dependent protein kinase II during the development of hypertrophy in neonatal cardiomyocytes.Loss of MD1 exacerbates pressure overload-induced left ventricular structural and electrical remodelling.Inhibition of CaMKII does not attenuate cardiac hypertrophy in mice with dysfunctional ryanodine receptorCaMKII-dependent phosphorylation of cardiac ryanodine receptors regulates cell death in cardiac ischemia/reperfusion injury.Differential cardiac remodeling in preload versus afterload.Left ventricular and aortic dysfunction in cystic fibrosis mice.Epac2 mediates cardiac β1-adrenergic-dependent sarcoplasmic reticulum Ca2+ leak and arrhythmia.Long-term simulated microgravity causes cardiac RyR2 phosphorylation and arrhythmias in mice.
P2860
Q24336808-F3D60EEC-49D7-486A-9C7A-763DE93D873AQ24568237-AC8F5F4E-D602-43FD-B778-E49564596EAFQ26746907-C98F71D7-8591-4A94-9E07-C9A78940DD42Q26785302-8B565619-264D-4527-A80A-C98A33D5CE73Q26825154-E668A2E8-8BED-48C2-B0C4-2E745FF0873EQ26864362-B9FD5DF7-2E75-4A8A-9E58-96E780744C2CQ26999872-29654EAB-0BC1-46CC-A062-89E32FC7F7DEQ27012758-671B9BEA-4AEB-452E-9931-F9F46F449B91Q27016402-0A4965D8-07E7-4771-9776-77A80C77FDF6Q27026987-0F0691B3-A221-45AB-ADD2-079747AD6FC9Q27027023-C8D87880-DCCB-4717-9E60-CA8AE479873EQ27339434-99CDB8C0-AE7B-4969-A483-5AEA1D8D360CQ28544014-7AF7218C-EFAB-4FB5-AB83-114BFA0D9C82Q28568044-29DAE564-58C6-49B8-939B-2CDFA032BC7EQ28571438-C88FC82A-33FC-4C16-A71E-087B749C148AQ28582985-0BE18633-9C54-42E6-8860-329B5618589DQ28592852-F9BAF038-E6F3-44A6-AAC2-8829BC552458Q28740422-762F7FBA-4B83-42BD-8B0F-28E49AA28A90Q30495045-B30D8678-3E1A-4B19-8884-51F16BF60984Q30540314-693602B1-3A7A-4EED-BE25-3C0EF2D9DE54Q30973910-DEE1866A-AACC-415A-A28B-A434A3A9BCABQ33517622-96D1C0C5-CE66-46B8-8EDA-1694FE731EC9Q33561848-3439C758-4C27-403C-923F-C216C409FDBEQ33604010-9D32973E-C065-44CB-A91B-6AC62644496FQ33639652-6A7CA4FB-EF64-4D7F-B017-EB0EE731A991Q33659776-D22BC9E2-80A9-46B1-9F8A-62A2F63F8C3CQ33685872-D1CA97E1-1449-4582-9394-1E132ACAA9DAQ33740283-6FCCE433-40B7-4A13-A6CE-CD9EA313C0E5Q33792957-FE581D24-3296-4BE8-A77E-6896009AC9BAQ33828730-ED505C76-2878-48C2-B91A-7E66D7860C9FQ33840022-563A7863-C20F-4446-99DF-C08FE4934392Q33864453-7729BEDC-C51D-44BC-827A-57ADF9B34783Q33886760-41D93986-1F4D-4D24-BECD-34492F849816Q33894807-968AE7F4-CAE1-48C8-9383-65BF545AA564Q34004829-8D8BCF43-ED86-4D5C-875C-237330F61C4FQ34038882-E0BFD295-9B50-4C2B-870E-9E57DB9ADA16Q34200561-F67FDCC5-DB57-463C-B46C-5FFA3524F30BQ34223037-AA7264D3-2174-4E34-948E-04AA404A0F71Q34325276-6E9E398D-261F-4FBB-A0ED-846BDE363C35Q34332569-67E0AD82-FA7E-4262-AC84-1D310EBE65B1
P2860
Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Requirement for Ca2+/calmoduli ...... ophy to heart failure in mice.
@en
Requirement for Ca2+/calmoduli ...... ophy to heart failure in mice.
@nl
type
label
Requirement for Ca2+/calmoduli ...... ophy to heart failure in mice.
@en
Requirement for Ca2+/calmoduli ...... ophy to heart failure in mice.
@nl
prefLabel
Requirement for Ca2+/calmoduli ...... ophy to heart failure in mice.
@en
Requirement for Ca2+/calmoduli ...... ophy to heart failure in mice.
@nl
P2093
P2860
P50
P356
P1476
Requirement for Ca2+/calmoduli ...... rophy to heart failure in mice
@en
P2093
Christopher Kable Means
Haiyun Ling
Joan Heller Brown
Kirk L Peterson
Nancy D Dalton
Tong Zhang
P2860
P304
P356
10.1172/JCI38022
P407
P577
2009-04-20T00:00:00Z